Chemours Co (CC)
Return on total capital
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 372,000 | 274,000 | 303,000 | -224,000 | -108,000 | -115,000 | 148,000 | 733,000 | 832,000 | 1,067,000 | 1,012,000 | 904,000 | 709,000 | 608,000 | 456,000 | 434,000 | 448,000 | -59,000 | -39,000 | 56,000 |
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 604,000 | 657,000 | 723,000 | 752,000 | 737,000 | 755,000 | 808,000 | 1,227,000 | 1,107,000 | 1,284,000 | 1,214,000 | 1,166,000 | 1,081,000 | 998,000 | 898,000 | 850,000 | 813,000 | 732,000 | 657,000 | 655,000 |
Return on total capital | 61.59% | 41.70% | 41.91% | -29.79% | -14.65% | -15.23% | 18.32% | 59.74% | 75.16% | 83.10% | 83.36% | 77.53% | 65.59% | 60.92% | 50.78% | 51.06% | 55.10% | -8.06% | -5.94% | 8.55% |
December 31, 2024 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $372,000K ÷ ($—K + $604,000K)
= 61.59%
The return on total capital of Chemours Co has shown significant fluctuations over the reported periods. It started positively at 8.55% in March 2020, but turned negative in the subsequent quarters, reaching its lowest point at -29.79% in March 2024. Thereafter, there was a notable recovery, with the return on total capital rebounding to 61.59% by December 2024. This erratic performance indicates varying levels of efficiency in generating profits relative to the total capital employed by the company.
Peer comparison
Dec 31, 2024
Company name
Symbol
Return on total capital
Chemours Co
CC
61.59%
Balchem Corporation
BCPC
15.90%
FMC Corporation
FMC
10.85%
Ingevity Corp
NGVT
189.04%
Innospec Inc
IOSP
14.69%
Olin Corporation
OLN
16.52%